^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Chordoma
    Drug:imatinib (c-KIT inhibitor, Bcr-abl tyrosine kinase inhibitor, PDGFR inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Chordoma: Other Recommended Regimens…Imatinib. Useful in Certain Circumstances…Imatinib with cisplatin....Imatinib with cisplatin or sirolimus
    Secondary therapy:
    sirolimus; cisplatin